DK1251835T3 - Lukning af bakterielle spögelser - Google Patents

Lukning af bakterielle spögelser

Info

Publication number
DK1251835T3
DK1251835T3 DK01916954T DK01916954T DK1251835T3 DK 1251835 T3 DK1251835 T3 DK 1251835T3 DK 01916954 T DK01916954 T DK 01916954T DK 01916954 T DK01916954 T DK 01916954T DK 1251835 T3 DK1251835 T3 DK 1251835T3
Authority
DK
Denmark
Prior art keywords
ghosts
closed
bacterial ghosts
closure
bacterial
Prior art date
Application number
DK01916954T
Other languages
Danish (da)
English (en)
Inventor
Susanne Paukner
Werner Lubitz
Original Assignee
Lubitz Werner Prof Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubitz Werner Prof Dr filed Critical Lubitz Werner Prof Dr
Application granted granted Critical
Publication of DK1251835T3 publication Critical patent/DK1251835T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Specific Sealing Or Ventilating Devices For Doors And Windows (AREA)
  • Revetment (AREA)
DK01916954T 2000-01-26 2001-01-26 Lukning af bakterielle spögelser DK1251835T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10003241A DE10003241A1 (de) 2000-01-26 2000-01-26 Verschließen von Bakterienghosts
PCT/EP2001/000864 WO2001054672A2 (fr) 2000-01-26 2001-01-26 Fermeture d'hotes bacteriens

Publications (1)

Publication Number Publication Date
DK1251835T3 true DK1251835T3 (da) 2008-12-08

Family

ID=7628743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01916954T DK1251835T3 (da) 2000-01-26 2001-01-26 Lukning af bakterielle spögelser

Country Status (12)

Country Link
US (1) US6951756B2 (fr)
EP (1) EP1251835B1 (fr)
JP (1) JP5073904B2 (fr)
AT (1) ATE404181T1 (fr)
AU (2) AU4410901A (fr)
CA (1) CA2423122C (fr)
DE (2) DE10003241A1 (fr)
DK (1) DK1251835T3 (fr)
ES (1) ES2307602T3 (fr)
NZ (1) NZ520655A (fr)
PT (1) PT1251835E (fr)
WO (1) WO2001054672A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002101026A2 (fr) 2001-06-11 2002-12-19 Applied Nanosystems B.V. Technique amelioree permettant de fixer des fusions d'ancrage de proteines de type acma a la paroi cellulaire de micro-organismes
DE10335796A1 (de) * 2003-08-05 2005-03-03 Lubitz, Werner, Prof. Dr. Verschliessen von Bakterienghosts durch bioaffine Wechselwirkungen
WO2005030122A2 (fr) * 2003-08-13 2005-04-07 Chiron Corporation Liberation de cellule hote inactivee comprenant des polynucleotides codant pour des immunogenes
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
CA2543257C (fr) 2003-10-24 2013-12-31 Gencia Corporation Procedes et compositions permettant de distribuer des polynucleotides
US8029777B2 (en) * 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
CN102078622A (zh) 2004-08-13 2011-06-01 巴里.J.马沙尔 细菌递送系统
GB2424408A (en) * 2005-03-24 2006-09-27 Micap Plc Encapsulation using microbial cells
AU2009204952B2 (en) 2008-01-18 2013-02-07 Werner Lubitz Bacterial ghost (BG) production process using betapropiolactone (BLP) for final inactivation
CN101658668B (zh) * 2009-07-15 2012-01-25 吉林大学 利用抗菌肽制备细菌菌影的方法及应用
EP2485764A4 (fr) * 2009-10-09 2014-01-29 Childrens Medical Center Vaccin à cellules entières à dissociation sélective
CN103079592B (zh) 2010-07-01 2015-10-21 浦项工科大学校产学协力团 使用来自细胞的微泡治疗和诊断癌症的方法
WO2013034687A1 (fr) 2011-09-09 2013-03-14 Universität Bern Verwaltungsdirektion Toxine rtx d'avibacterium paragallinarum
ES2525205T3 (es) * 2011-11-09 2014-12-18 Werner Lubitz Vacuna para su uso en inmunoterapia tumoral
EP3195878A1 (fr) 2016-01-22 2017-07-26 Werner Lubitz Hôtes bactériens pour le traitement du cancer
US20210085615A1 (en) * 2017-07-28 2021-03-25 National University Of Singapore Biomolecular composites comprising modified cell ghosts
AU2018316166A1 (en) 2017-08-07 2020-02-06 The Regents Of The University Of California Platform for generating safe cell therapeutics
US10960071B2 (en) * 2017-08-07 2021-03-30 The Regents Of The University Of California Platform for generating safe cell therapeutics
JP7376208B2 (ja) 2017-10-25 2023-11-08 アレーロ セラピューティクス ビーヴイ 抗原特異的製剤の投与による免疫疾患の治療
CN108324956A (zh) * 2018-03-06 2018-07-27 东北农业大学 一种以大肠杆菌菌影为载体装载紫杉醇药物的制备方法
CN108587961A (zh) * 2018-04-28 2018-09-28 南华大学 一种制备大肠埃希菌菌影并装载dna质粒的方法
EP4013392A4 (fr) * 2019-09-13 2023-07-19 Exocure Biosciences, Inc. Utilisation de nanovésicules fantômes en tant qu'agents thérapeutiques
CN115666524A (zh) * 2021-08-16 2023-01-31 于仙忠 密封的细菌菌影及其组合物、方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269886D1 (en) * 1981-11-21 1986-04-17 Dunlop Ltd Process for encapsulating substances by means of microorganisms, and the encapsulated products obtained thereby
JPS6188871A (ja) * 1984-10-04 1986-05-07 Mitsubishi Paper Mills Ltd 感圧性バイオカプセル
JPS62186937A (ja) * 1986-02-10 1987-08-15 Mitsubishi Paper Mills Ltd マイクロカプセルの製造方法
DD246476A1 (de) * 1986-03-12 1987-06-10 Karl Marx Stadt Tech Hochschul Einteilige zementfrei verankerbare biokompatible hueftgelenkpfanne
JPH0732870B2 (ja) * 1990-04-20 1995-04-12 三菱製紙株式会社 マイクロカプセルの製造方法
GB9509937D0 (en) * 1995-05-17 1995-07-12 Cpc International Inc Encapsulated product
JPH10102288A (ja) * 1996-09-24 1998-04-21 Queen Mary & Westfield College リン酸カルシウム化合物のコーティング方法
US6013591A (en) * 1997-01-16 2000-01-11 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
WO1999011202A1 (fr) * 1997-09-05 1999-03-11 Icet, Inc. Revetements d'implants au phosphate de calcium biomimetique et leurs methodes de production

Also Published As

Publication number Publication date
US20030003511A1 (en) 2003-01-02
CA2423122A1 (fr) 2003-03-19
JP2003521494A (ja) 2003-07-15
ATE404181T1 (de) 2008-08-15
AU2001244109B2 (en) 2004-12-02
CA2423122C (fr) 2014-04-01
US6951756B2 (en) 2005-10-04
AU2001244109B9 (en) 2005-05-26
JP5073904B2 (ja) 2012-11-14
ES2307602T3 (es) 2008-12-01
DE50114213D1 (de) 2008-09-25
WO2001054672A2 (fr) 2001-08-02
EP1251835A2 (fr) 2002-10-30
EP1251835B1 (fr) 2008-08-13
AU4410901A (en) 2001-08-07
WO2001054672A3 (fr) 2002-01-17
PT1251835E (pt) 2008-11-25
DE10003241A1 (de) 2001-08-02
NZ520655A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
DK1251835T3 (da) Lukning af bakterielle spögelser
GEP20094620B (en) Irinotecan preparation
WO2007077217A3 (fr) Milieux de culture cellulaire dépourvus d'oligopeptides
WO2009091912A3 (fr) Vecteurs d'expression de mammifère améliorés et leurs utilisations
WO2002061111A3 (fr) Cellules competentes stables a la temperature ambiante
DK1196196T3 (da) Konjugat til formidling af en celle-, compartment- eller membranspecifik transport af aktivstoffer
Dabravolski et al. Metabolites facilitating adaptation of desert cyanobacteria to extremely arid environments
WO2005084355A3 (fr) Proteines hybrides complexes de toxines insecticides
WO2003021265A8 (fr) Systeme de controle intracellulaire d'un produit de recombinaison genetique
WO2001049106A3 (fr) Procede de clonage d'animaux avec modifications genetiques ciblees, par transfert de noyaux cellulaires somatiques males ou femelles a culture a long terme, comprenant des modifications genetiques provoquees artificiellement, dans des cellules receveuses enuclees
ATE284140T1 (de) Konservierung von zellen
EE05691B1 (et) Ekspressioonivektorid ja nende rakendused
WO2005123903A3 (fr) Auxiliaire de culture pour cellules et tissus
Niederman Eukaryotic behaviour of a prokaryotic energy‐transducing membrane: fully detached vesicular organelles arise by budding from the Rhodobacter sphaeroides intracytoplasmic photosynthetic membrane
Dunnebacke The ameba Balamuthia mandrillaris feeds by entering into mammalian cells in culture
WO2011104612A3 (fr) Dispositif pour la culture et l'analyse cellulaires
CA2534612A1 (fr) Scellement d'hotes bacteriens par des interactions a affinite biologique
Malda et al. Does scaffold architecture influence oxygen gradients in cartilaginous tissue engineered constructs?
WO2002047479A3 (fr) Clonage de bovins par transplantation nucleaire
IL154690A0 (en) Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
WO2000075291A3 (fr) Expression forcee de bcl-xl
WO2007027947A3 (fr) Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport
Tollefson Garden Planting Welcomes Summer to Campus
Katz Chemical modifications to vesicle forming diblock copolymers: Development of smart functional polymersome membranes
CN108966941A (zh) 一种组合塑料膜